GH RESEARCH PLC GHRS
ORDINARY SHARES · Common Stock · CUSIP G3855L106
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $21.52.
Biggest buyers
| BVF INC/IL | New | +9.3m |
| RA CAPITAL MANAGEMENT, L.P. | New | +3.0m |
| RTW INVESTMENTS, LP | New | +2.2m |
| ORBIMED ADVISORS LLC | New | +1.4m |
| FMR LLC | New | +1.4m |
| Verition Fund Management LLC | New | +1.3m |
| CITADEL ADVISORS LLC | New | +1.3m |
| Venrock Adviser, LLC | New | +1.3m |
| Boxer Capital, LLC | New | +1.0m |
| Logos Global Management LP | New | +724.3k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Lynx1 Capital Management LP 13G · passive investor +1.9 pts · filed 2026-08-14 | 19.3% |
| BIOTECHNOLOGY VALUE FUND L P 13G · exempt (held before listing) filed 2025-05-15 | 14.2% |
| RTW INVESTMENTS, LP 13G · institution filed 2025-05-15 | 8.9% |
| FMR LLC 13G · institution +1.3 pts · filed 2025-08-06 | 8.2% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor -5.3 pts · filed 2026-08-14 | 7.1% |
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2021.
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| BVF INC/IL 7.55% of their portfolio | 9.3m $201.5m | New |
| RA CAPITAL MANAGEMENT, L.P. 1.04% of their portfolio | 3.0m $64.7m | New |
| RTW INVESTMENTS, LP 0.64% of their portfolio | 2.2m $42.7m | New |
| ORBIMED ADVISORS LLC 0.31% of their portfolio | 1.4m $31.0m | New |
| FMR LLC 0.00% of their portfolio | 1.4m $29.6m | New |
| Verition Fund Management LLC 0.43% of their portfolio | 1.3m $29.1m | New |
| CITADEL ADVISORS LLC 0.03% of their portfolio | 1.3m $27.1m | New |
| Venrock Adviser, LLC 3.36% of their portfolio | 1.3m $27.7m | New |
| Boxer Capital, LLC 0.78% of their portfolio | 1.0m $22.0m | New |
| Logos Global Management LP 1.35% of their portfolio | 724.3k $15.7m | New |
| Cormorant Asset Management, LP 0.49% of their portfolio | 608.1k $12.6m | New |
| Avidity Partners Management LP 0.33% of their portfolio | 560.0k $12.2m | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.21% of their portfolio | 555.4k $12.1m | New |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% of their portfolio | 465.0k $10.1m | New |
| TimesSquare Capital Management, LLC 0.08% of their portfolio | 422.3k $9.2m | New |
| PURA VIDA INVESTMENTS, LLC 0.62% of their portfolio | 400.0k $8.7m | New |
| Laurion Capital Management LP 0.12% of their portfolio | 360.0k $7.8m | New |
| HealthCor Management, L.P. 0.22% of their portfolio | 250.0k $5.4m | New |
| MORGAN STANLEY 0.00% of their portfolio | 201.7k $4.4m | New |
| Monashee Investment Management LLC 0.43% of their portfolio | 165.0k $3.6m | New |
| ACUTA CAPITAL PARTNERS, LLC 1.40% of their portfolio | 150.0k $3.3m | New |
| Woodline Partners LP 0.06% of their portfolio | 138.9k $3.0m | New |
| Alyeska Investment Group, L.P. 0.03% of their portfolio | 100.0k $2.2m | Not comparable |
| Maven Securities LTD 0.23% of their portfolio | 100.0k $2.2m | New |
| Walleye Capital LLC 0.07% of their portfolio | 85.1k $1.8m | New |
| Pinz Capital Management, LP 0.45% of their portfolio | 68.5k $1.5m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 45.9k $997.0k | New |
| Polar Asset Management Partners Inc. 0.01% of their portfolio | 19.6k $426.0k | New |
| Squarepoint Ops LLC 0.00% of their portfolio | 18.0k $391.0k | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 17.5k $381.0k | New |
| CAPSTONE INVESTMENT ADVISORS, LLC 0.01% of their portfolio | 10.0k $217.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 1.0k $21.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 837 $18.0k | New |
| UBS Group AG 0.00% of their portfolio | 335 $7.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |